Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination RegimesArticle Published on 2022-10-132022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accompanied antibody Antibody Response AstraZeneca B cell benefit booster vaccination cells Comparative courses COVID-19 COVID-19 pandemic Critical critical COVID-19 patients exceeded follicular Frequency Infection Inflammation Inflammatory response Johnson & Johnson long-COVID Lymphocytes Mild Moderna mRNA vaccine neutralizing antibody patients patients who survived Pfizer-BioNTech recommendation reduced regime SARS-CoV-2 SARS-CoV-2 patient severe COVID-19 disease the SARS-CoV-2 virus the Spike titer understanding vaccination Vaccination strategy Vaccine [DOI] 10.3390/ijms232012231 PMC 바로가기
SARS-CoV-2-Specific IgG and IgA response in maternal blood and breastmilk of vaccinated naïve and convalescent lactating participantsArticle Published on 2022-10-032022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, [키워드] addition adenovirus vaccine Analysis anti-SARS-CoV-2 IgG Anti-spike AstraZeneca BBIBP-CorV Blood Breastfeeding breastmilk ChAdOx1-S children Cohort convalescent COVID-19 COVID-19 vaccine cross-sectional decrease eligible evaluated IgA IgA level IgA response IgG IgG level immune response inactivated Infection information lactating lactating women mother mRNA naïve Newborn no significant difference Oxford participant passive immunity positive receive receiving recent SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccine SARS-CoV-2-specific antibody second dose serum serum sample shown significantly higher Sinopharm Sputnik V vaccination Vaccine vaccine platform Vaccines women [DOI] 10.3389/fimmu.2022.909995 PMC 바로가기
Heterologous adenovirus-vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipientsArticle Published on 2022-10-012022-11-15 Journal: Hepatology communications [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI 95% confidence interval acute respiratory syndrome Analysis analyzed Anti-spike anti-Spike IgG Antibody Response AstraZeneca BBIBP-CorV BMI booster response ChAdOx1 Clinical data collected Combination Concentration Control coronavirus correlation different dose dose evaluate evaluated Future groups healthy volunteer Heterologous homologous humoral IgG immunized Immunoglobulin inactivated information liver LTR LTRs Messenger RNA MMF neutralizing antibody nucleocapsid protein Odds ratio positive positive serology Probability prospective cohort study R 2 receiving recipient reduced reduction regimen reported RNA SARS-CoV-2 SARS-CoV-2 anti-spike IgG Serious Adverse Event Side effects significant difference significantly significantly higher Sinopharm Vaccine vaccine dose vaccine platform [DOI] 10.1002/hep4.2034 PMC 바로가기
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literatureArticle Published on 2022-10-012022-11-15 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome Adults affected analysed antibody AstraZeneca attack available data AZD1222 blindness BNT162b2 booster vaccination Brain Brainstem Brainstem encephalitis Case report cerebrospinal fluid ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1-S CNS complete recovery coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-2019) COVID-19 CSF detectable disease dysfunction Encephalitis epidemiological Escalation exceeded female first dose functional glycoprotein IgG1 immunization Immunoglobulin Immunotherapy laboratory feature Longitudinally extensive transverse myelitis (LETM) majority male median median age median interval MOG MOG antibodies (MOG-IgG) mRNA vaccine mRNA-1273 much lower Myelin Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) Myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM) Myelitis Neuromyelitis Optica Neuromyelitis optica spectrum disorders occur occurred Optic Optic neuritis Oxford paraplegia Patient patients patients with SARS-CoV-2 Pfizer phenotype plasma Postinfectious Postvaccinal predominant radiological remained required residual symptom SARS-CoV2 serum Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) severity steroid treatment therapy Treatment Treatment outcome vaccination Vaccine WCC white cell [DOI] 10.1007/s00415-022-11194-9 PMC 바로가기
Immunological study of COVID-19 vaccine candidate based on recombinant spike trimer protein from different SARS-CoV-2 variants of concernArticle Published on 2022-09-292022-11-15 Journal: Frontiers in Immunology [Category] SARS, 변종, 진단, [키워드] addition AstraZeneca Beta booster booster dose CD4 CD4+ CD8+ central memory ChAdOx1 Concentration COVID-19 COVID-19 vaccine Delta evaluated follicular highest homologous IFN-gamma IgG IgG antibody IgG isotype IL-17 Immune escape immunogenic immunogenicity induce memory mice mice immunization neutralizing antibody Neutralizing antibody titer new SARS-CoV-2 performed Population populations Protein S protein SARS-CoV-2 SARS-CoV-2 S protein SARS-CoV-2 variant SARS-CoV-2 variants significantly higher spike trimer spike trimeric protein T cells tested trimeric Trimeric spike protein Vaccine vaccine candidate Vaccines variant variants viral variant virus viruses VoC Wuhan [DOI] 10.3389/fimmu.2022.1020159 PMC 바로가기
Saliva is suitable for SARS-CoV-2 antibodies detection after vaccination: A rapid systematic reviewArticle Published on 2022-09-202022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료기술, [키워드] 95% CI Ad26 analyzed anti-SARS-CoV-2 anti-SARS-CoV-2 vaccination antibodies antibody Antibody detection Antibody titer applied assays AstraZeneca convalescent individual correlation COVID-19 COVID-19 vaccines eligible ELISA assay evaluate flow cytometry highlight IgA IgG Immunity immunoassay Immunoglobulin immunological increasingly infected individuals janssen Johnson & Johnson lack moderate mRNA-based mucosal Neutralizing nine quantification reached reported Saliva salivary SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 detection selected serological test serum serum/plasma systematic review vaccinated individual vaccination Vaccination strategy Vaccine Web of Science [DOI] 10.3389/fimmu.2022.1006040 PMC 바로가기
COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case seriesShort communication Published on 2022-09-012022-10-05 Journal: Journal of the neurological sciences [Category] 변종, 유전자 메커니즘, [키워드] adverse event Affect age AstraZeneca Bilateral case sery characterized clinical clinical feature cohort of patient collected COVID-19 COVID-19 vaccination COVID-19 vaccines cranial dose feature first vaccination fluctuations Guillain-barrè syndrome hospital Inflammatory Italy Liguria Mild symptom Moderna multicenter negatively affected occur Oxford-AstraZeneca Patient patients Peripheral nervous system Pfizer-BioNTech post-COVID-19 vaccination predominant Prognosis Region Result SARS-CoV-2 second dose syndrome Treatment vaccination vaccine dose variant [DOI] 10.1016/j.jns.2022.120330 [Article Type] Short communication
Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance databaseArticle Published on 2022-09-012022-11-16 Journal: Journal of the peripheral nervous system : JPNS [Category] 변종, [키워드] acute respiratory syndrome Administered Analysis association AstraZeneca Cambridge cause ChAdOx1 nCoV-19 coronavirus coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccine database demonstrated Encephalitis Epidemiological study greater Guillain-barrè syndrome Guillain-Barré syndrome variants heterogeneity higher risk Influenza influenza vaccine influenza vaccines information median time Moderna mRNA-based vaccine Occurrence Odds ratio Pfizer reported risk SARS-CoV-2 syndrome the WHO vaccination Vaccines variant World Health Organization [DOI] 10.1111/jns.12507 PMC 바로가기
Emotional profiling and cognitive networks unravel how mainstream and alternative press framed AstraZeneca, Pfizer and COVID-19 vaccination campaigns Research Published on 2022-08-242022-10-05 Journal: Scientific Reports [Category] 치료기술, 치료법, [키워드] adopted article association AstraZeneca cause changed cognitive COVID-19 vaccination COVID-19 vaccine death deaths Efficacy emotional Frame highlighting Initially Italian mainstream media New Pfizer positive press reported Side effect Side effects thrombosis vaccination Vaccine Vaccines [DOI] 10.1038/s41598-022-18472-6 [Article Type] Research
Lowered Quality of Life in Long COVID Is Predicted by Affective Symptoms, Chronic Fatigue Syndrome, Inflammation and Neuroimmunotoxic Pathways긴 COVID에서 삶의 질 저하가 정동 증상, 만성 피로 증후군, 염증 및 신경 면역 독성 경로에 의해 예측됩니다Article Published on 2022-08-192022-09-11 Journal: International Journal of Environmental Research an [Category] 바이오마커, [키워드] Activation acute infection Affect Anxiety AstraZeneca Biomarker body temperature calcium caspase caspase-1 chronic chronic fatigue syndrome controls COVID COVID-19 Depression domain Effect explained fatigue fatigue syndrome female fibromyalgia Health Organization IL-18 immune Inflammation inflammatory biomarkers insulin insulin resistance life Long Long COVID Myalgic encephalomyelitis/chronic fatigue syndrome myeloperoxidase neuro-immune neurotoxicity oxidative stress oxygen oxygen saturation participant pathway Pfizer physical predicted Protein psychiatry Psychological Quality Quality of life rating scales recruited Regression serum severity Sex SpO2 subsequent Switzerland vaccination variance Version World Health Organization yielding [DOI] 10.3390/ijerph191610362 PMC 바로가기 [Article Type] Article